37 /100
MEDIUM RISK
Score updated May 30, 2026

CUE — Cue Biopharma, Inc. Dilution Risk Tracker

Track CUE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CUE — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
20%
📉 Score Deterioration 40%
• Score rose 17 points recently (worsening)
🔔 Track CUE — Get forecast alerts →

💹 Market Data

Market Cap$88.60M
Shares Outstanding4.05M
Float3.61M
Cash$17.44M
Debt$3.44M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 22.1% shares (2025Q4 vs prior)
48 institutional holders · 22.13M shares
#1 Bleichroeder LP 6.82M shares
#2 GC Wealth Management RIA, LLC 4.63M shares
#3 VANGUARD GROUP INC 3.01M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest255.2K
Days to Cover1.0
% of Float7.1%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2017
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track CUE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CUE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for CUE
📊 CUE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CUE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.